LivingGLP1
Study S002249

Effect of Liraglutide on Different Parameters (Clinical , Metabolic and Hormonal) in Obese Women With Polycystic Ovary Syndrome

Registration

Registration
NCT05965908
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Phase
PHASE3
Masking
NONE
Status
COMPLETED
Enrollment
183
Start
2024-08-01
Primary completion
2025-11-30
Lead sponsor
Beni-Suef University
Conditions
Polycystic Ovary
Interventions
DRUG:liraglutide; DRUG:Metformin
Results posted
FALSE
Individual participant data sharing
YES

Registered primary outcomes

  • Insulin Resistance (HOMA-IR) [6-months]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.